Particle.news

Download on the App Store

£1 Billion London Cancer Hub Planning Application Submitted

Aviva Capital Partners and Socius propose a transformative cancer research and treatment hub in Sutton, with a council decision expected by autumn 2025.

Overview

  • The £1 billion masterplan aims to create a world-leading cancer research and treatment hub on a 12-acre site in Sutton, anchored by The Institute of Cancer Research and The Royal Marsden.
  • The proposed development includes one million square feet of state-of-the-art laboratories, offices, and incubator spaces for global pharmaceutical companies and start-ups.
  • If approved, construction is set to begin in 2026, with the first phase expected to be completed by 2028, creating 3,000 high-skilled jobs in life sciences and 340 annual construction roles.
  • Community-focused amenities include affordable housing for 220 key workers, restaurants, a creche, a pub for informal collaboration, and interim padel courts.
  • Public consultation with over 4,500 residents informed the plans, which promise £54 million in long-term social value through job creation, public amenities, and health improvements.